Co-Diagnostics, Inc. (LSE:0A50) Financings

Co-Diagnostics, Inc.

Financings

RaiseDate
Registered direct offering of shares of common stock (or pre-funded warrants in-lieu thereof)
Closed: US$7M raised · US$0.55 a share · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Oct 29, 2025
Registered direct offering of common stock
Closed: US$3.8M raised · US$0.4 a share · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Sep 18, 2025

Read by 6ix AI from the company's releases